|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
EP1005544A4
(en)
|
1997-08-19 |
2004-07-14 |
Human Genome Sciences Inc |
70 human secreted proteins
|
|
DE69837606T2
(en)
|
1997-09-12 |
2008-02-14 |
Biogen Idec Ma Inc., Cambridge |
CYSTEIN RICH RECEPTORS TRAIN
|
|
US6849719B2
(en)
|
1997-09-17 |
2005-02-01 |
Human Genome Sciences, Inc. |
Antibody to an IL-17 receptor like protein
|
|
EP1015488B1
(en)
*
|
1997-09-17 |
2009-09-09 |
Human Genome Sciences, Inc. |
Interleukin-17 receptor-like protein
|
|
US20030039648A1
(en)
|
1998-09-16 |
2003-02-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US20030130182A1
(en)
*
|
1997-11-05 |
2003-07-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
EP2333069A3
(en)
|
1998-05-15 |
2011-09-14 |
Genentech, Inc. |
Therapeutic uses of IL-17 homologous polypeptides
|
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
|
US20030009013A1
(en)
|
1998-12-30 |
2003-01-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6291663B1
(en)
*
|
1999-03-03 |
2001-09-18 |
Board Of Trustees Of The University Of Arkansas |
TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
|
|
US8133734B2
(en)
|
1999-03-16 |
2012-03-13 |
Human Genome Sciences, Inc. |
Kit comprising an antibody to interleukin 17 receptor-like protein
|
|
MXPA01011519A
(en)
*
|
1999-05-13 |
2003-08-20 |
Medical Res Council |
Ox2 receptor homologs.
|
|
US7034132B2
(en)
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
EP1623993A3
(en)
*
|
1999-09-01 |
2006-06-07 |
Genetech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1230349B1
(en)
|
1999-11-18 |
2007-06-13 |
Dendreon Corporation |
Nucleic acids encoding endotheliases, endotheliases and uses thereof
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
DK1897947T3
(en)
*
|
1999-12-23 |
2012-04-10 |
Genentech Inc |
IL-17 homologous polypeptides and their therapeutic uses
|
|
US20020164745A1
(en)
*
|
2000-06-15 |
2002-11-07 |
Meyers Rachel A. |
53320, a novel human acyltransferase and uses therefor
|
|
US7094566B2
(en)
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
AU2001259271A1
(en)
|
2000-04-28 |
2001-11-12 |
Millennium Pharmaceuticals, Inc. |
14094, a novel human trypsin family member and uses thereof
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
|
MXPA02012106A
(en)
|
2000-06-06 |
2003-06-06 |
Bristol Myers Squibb Co |
B7-related nucleic acids and polypeptides useful for immunomodulation.
|
|
CA2413986A1
(en)
*
|
2000-06-22 |
2001-12-27 |
Biogen, Inc. |
Gp354 nucleic acids and polypeptides
|
|
US20020061574A1
(en)
*
|
2000-09-01 |
2002-05-23 |
Rachel Meyers |
16658, 14223, and 16002, novel human kinases and uses therefor
|
|
US20020165347A1
(en)
*
|
2000-06-30 |
2002-11-07 |
Amgen, Inc. |
B7-like molecules and uses thereof
|
|
CA2416732C
(en)
|
2000-08-02 |
2016-02-09 |
Brad St. Croix |
Endothelial cell expression patterns
|
|
CA2420392A1
(en)
*
|
2000-08-28 |
2002-03-07 |
Human Genome Sciences, Inc. |
17 human secreted proteins
|
|
AU2001294703A1
(en)
*
|
2000-09-25 |
2002-04-08 |
Millennium Pharmaceuticals, Inc. |
32624 a novel human udp-glucuronosyl and glycosyl transferase family member and uses thereof
|
|
CA2429179A1
(en)
|
2000-11-14 |
2002-06-23 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01
|
|
DE10106835A1
(en)
*
|
2001-02-14 |
2002-09-05 |
Basf Lynx Bioscience Ag |
Signal transduction proteins 15B3, 15B3-1 and 15B3-2 and underlying DNA sequences
|
|
WO2002064769A1
(en)
*
|
2001-02-15 |
2002-08-22 |
Shionogi & Co., Ltd. |
Novel disease marker
|
|
EP1873245A1
(en)
*
|
2001-02-28 |
2008-01-02 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
EP1409655A4
(en)
*
|
2001-03-12 |
2005-04-06 |
Incyte Genomics Inc |
Immunoglobulin superfamily proteins
|
|
AU2002305052A1
(en)
|
2001-03-13 |
2002-09-24 |
Corvas International, Inc. |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
|
AU2002254357A1
(en)
|
2001-03-22 |
2002-10-08 |
Dendreon Corporation |
Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
|
|
US7105333B2
(en)
|
2001-03-27 |
2006-09-12 |
Deadreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
|
|
US7033790B2
(en)
|
2001-04-03 |
2006-04-25 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
EP2280030A3
(en)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
US7049096B2
(en)
|
2001-04-11 |
2006-05-23 |
Bristol-Meyers Squibb Company |
Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1
|
|
WO2002092841A2
(en)
|
2001-05-14 |
2002-11-21 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
|
|
US7125663B2
(en)
|
2001-06-13 |
2006-10-24 |
Millenium Pharmaceuticals, Inc. |
Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
|
|
AU2002322331B2
(en)
*
|
2001-06-22 |
2008-01-03 |
Biogen Idec Ma Inc. |
Pancam nucleic acids and polypeptides
|
|
WO2003004530A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human somatostatin receptor-like protein
|
|
CA2453653A1
(en)
*
|
2001-07-26 |
2003-02-06 |
Genset S.A. |
Gmg-2 polynucleotides and polypeptides and uses thereof
|
|
JP4702819B2
(en)
|
2001-08-01 |
2011-06-15 |
生化学工業株式会社 |
Chondroitin synthase
|
|
EP1428881A4
(en)
*
|
2001-08-23 |
2006-05-17 |
Japan Science & Tech Agency |
REGULATORS OF THE PROLIFERATION OF HEMATOPOIETIC STEM CELLS AND POLYNUCLEOTIDES ENCODING THESE REGULATORS
|
|
EP2151244A1
(en)
|
2001-09-18 |
2010-02-10 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
AU2002333862A1
(en)
*
|
2001-09-20 |
2003-04-01 |
Bayer Aktiengesellschaft |
Regulation of human prolyl 4-hydroxylase alpha subunit precursor
|
|
JP2005508171A
(en)
*
|
2001-11-02 |
2005-03-31 |
タノックス インコーポレーテッド |
B cell lymphoma specific antigen for use in diagnosis and prevention of B cell malignancy
|
|
WO2003054164A2
(en)
|
2001-12-19 |
2003-07-03 |
Immunex Corporation |
C-type lectin polypeptide, polynucleotide and methods of making and use thereof
|
|
DE10211088A1
(en)
*
|
2002-03-13 |
2003-09-25 |
Ugur Sahin |
Gene products differentially expressed in tumors and their use
|
|
MXPA04010091A
(en)
*
|
2002-04-17 |
2004-12-13 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor.
|
|
AU2003238178A1
(en)
|
2002-05-29 |
2003-12-12 |
Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
|
WO2003102182A1
(en)
*
|
2002-05-31 |
2003-12-11 |
Hidetoshi Inoko |
Inflammatory skin disease-related slurp-2 gene and utilization thereof
|
|
ATE388233T1
(en)
*
|
2002-05-31 |
2008-03-15 |
Seikagaku Kogyo Co Ltd |
CHONDROITIN SYNTHETASE AND NUCLEIC ACID ENCODING THE ENZYME
|
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
DE10242016A1
(en)
*
|
2002-09-11 |
2004-03-25 |
Esplora GmbH c/o TU Darmstadt Institut für Biochemie |
Identifying blood-brain barrier protein, useful e.g. as drug transporter and for treatment or diagnosis, by subtractive hybridization using cDNA from brain capillary cells
|
|
WO2004024077A2
(en)
*
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel composition and methods for the treatment of psoriasis
|
|
DE10254601A1
(en)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Gene products differentially expressed in tumors and their use
|
|
WO2004058817A1
(en)
*
|
2002-12-26 |
2004-07-15 |
Takeda Pharmaceutical Company Limited |
Novel proteins and use thereof
|
|
AU2003302753A1
(en)
*
|
2002-12-27 |
2004-08-10 |
Laboratoires Serono Sa |
Novel fibrillin-like polypeptides
|
|
US20060089297A1
(en)
*
|
2003-01-16 |
2006-04-27 |
Herr John C |
Sperm specific lysozyme-like proteins
|
|
US7312197B2
(en)
|
2003-02-24 |
2007-12-25 |
University Of Maryland, Baltimore |
Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
|
|
US20040185559A1
(en)
|
2003-03-21 |
2004-09-23 |
Isis Pharmaceuticals Inc. |
Modulation of diacylglycerol acyltransferase 1 expression
|
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
PL2784084T5
(en)
|
2003-07-08 |
2024-12-02 |
Novartis Pharma Ag |
Antagonist antibodies to IL-17A/F heterologous polypeptides
|
|
WO2005019270A2
(en)
|
2003-08-14 |
2005-03-03 |
Dyax Corp. |
Endotheliase-2 ligands
|
|
US7825235B2
(en)
|
2003-08-18 |
2010-11-02 |
Isis Pharmaceuticals, Inc. |
Modulation of diacylglycerol acyltransferase 2 expression
|
|
CA2551546A1
(en)
*
|
2003-12-24 |
2005-07-07 |
Takeda Pharmaceutical Company Limited |
Preventive/remedy for cancer
|
|
DE102004024617A1
(en)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentially expressed in tumors gene products and their use
|
|
JP2008505182A
(en)
|
2004-07-02 |
2008-02-21 |
ジェネンテック・インコーポレーテッド |
Compositions and methods for the treatment of non-Hodgkin lymphoma
|
|
US7846438B2
(en)
|
2004-08-03 |
2010-12-07 |
Biogen Idec Ma Inc. |
Methods of promoting neurite outgrowth with soluble TAJ polypeptides
|
|
CA2574881C
(en)
|
2004-08-04 |
2013-01-08 |
Amgen Inc. |
Antibodies to dkk-1
|
|
US7544659B2
(en)
|
2004-08-13 |
2009-06-09 |
Genentech, Inc. |
Promotion of axonal regeneration
|
|
CA2601677A1
(en)
*
|
2005-03-11 |
2006-09-21 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
BRPI0620601A2
(en)
|
2005-12-08 |
2011-11-16 |
Medarex Inc |
isolated human monoclonal antibody or antigen-binding portion thereof, composition, immunoconjugate, isolated nucleic acid molecule, expression vector, host cell, method for preparing an anti-o8e antibody and method for treating or preventing a disease defined by the growth of o8e expressing tumor cells
|
|
WO2007107774A2
(en)
*
|
2006-03-22 |
2007-09-27 |
Cartela R & D Ab |
Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
|
|
WO2008036437A2
(en)
*
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
US8003620B2
(en)
|
2006-08-04 |
2011-08-23 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to diacylglycerol acyltransferase 1
|
|
WO2008026010A1
(en)
|
2006-08-29 |
2008-03-06 |
Oxford Genome Sciences (Uk) Ltd |
Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer
|
|
US8058014B2
(en)
|
2006-09-29 |
2011-11-15 |
University Of Maryland, Baltimore |
Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2
|
|
KR20150002874A
(en)
|
2008-05-05 |
2015-01-07 |
노비뮨 에스 에이 |
Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
|
|
WO2009149021A2
(en)
|
2008-06-02 |
2009-12-10 |
Dana-Farber Cancer Institute, Inc. |
Xbp1, cd138, and cs1 peptides
|
|
KR101769160B1
(en)
|
2009-03-05 |
2017-08-17 |
옥스포드 바이오테라퓨틱스 리미티드 |
Fully human antibodies specific to cadm1
|
|
SG175276A1
(en)
|
2009-05-05 |
2011-11-28 |
Novimmune Sa |
Anti-il-17f antibodies and methods of use thereof
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
CN110787285B
(en)
|
2012-11-05 |
2025-06-13 |
达纳-法伯癌症研究所股份有限公司 |
XBP1, CD138 and CS1 peptides, pharmaceutical compositions comprising the peptides, and methods of using the peptides and compositions
|
|
KR102381936B1
(en)
|
2012-11-13 |
2022-04-01 |
비온테크 에스이 |
Agents for treatment of claudin expressing cancer diseases
|
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
US20180312845A1
(en)
|
2015-07-10 |
2018-11-01 |
Ionis Pharmaceuticals, Inc. |
Modulators of diacyglycerol acyltransferase 2 (dgat2)
|